168 related articles for article (PubMed ID: 22787087)
21. LAMB3 promotes tumour progression through the AKT-FOXO3/4 axis and is transcriptionally regulated by the BRD2/acetylated ELK4 complex in colorectal cancer.
Zhu Z; Song J; Guo Y; Huang Z; Chen X; Dang X; Huang Y; Wang Y; Ou W; Yang Y; Yu W; Liu CY; Cui L
Oncogene; 2020 Jun; 39(24):4666-4680. PubMed ID: 32398865
[TBL] [Abstract][Full Text] [Related]
22. The expression of ELK transcription factors in adult DRG: Novel isoforms, antisense transcripts and upregulation by nerve damage.
Kerr N; Pintzas A; Holmes F; Hobson SA; Pope R; Wallace M; Wasylyk C; Wasylyk B; Wynick D
Mol Cell Neurosci; 2010 Jun; 44(2):165-77. PubMed ID: 20304071
[TBL] [Abstract][Full Text] [Related]
23. Cyclin-dependent kinase 2 (CDK2) is a key mediator for EGF-induced cell transformation mediated through the ELK4/c-Fos signaling pathway.
Peng C; Zeng W; Su J; Kuang Y; He Y; Zhao S; Zhang J; Ma W; Bode AM; Dong Z; Chen X
Oncogene; 2016 Mar; 35(9):1170-9. PubMed ID: 26028036
[TBL] [Abstract][Full Text] [Related]
24. MKL1/2 and ELK4 co-regulate distinct serum response factor (SRF) transcription programs in macrophages.
Xie L
BMC Genomics; 2014 Apr; 15():301. PubMed ID: 24758171
[TBL] [Abstract][Full Text] [Related]
25. A fluorescence in situ hybridization screen for E26 transformation-specific aberrations: identification of DDX5-ETV4 fusion protein in prostate cancer.
Han B; Mehra R; Dhanasekaran SM; Yu J; Menon A; Lonigro RJ; Wang X; Gong Y; Wang L; Shankar S; Laxman B; Shah RB; Varambally S; Palanisamy N; Tomlins SA; Kumar-Sinha C; Chinnaiyan AM
Cancer Res; 2008 Sep; 68(18):7629-37. PubMed ID: 18794152
[TBL] [Abstract][Full Text] [Related]
26. Distinct classes of chromosomal rearrangements create oncogenic ETS gene fusions in prostate cancer.
Tomlins SA; Laxman B; Dhanasekaran SM; Helgeson BE; Cao X; Morris DS; Menon A; Jing X; Cao Q; Han B; Yu J; Wang L; Montie JE; Rubin MA; Pienta KJ; Roulston D; Shah RB; Varambally S; Mehra R; Chinnaiyan AM
Nature; 2007 Aug; 448(7153):595-9. PubMed ID: 17671502
[TBL] [Abstract][Full Text] [Related]
27. Deep RNA sequencing analysis of readthrough gene fusions in human prostate adenocarcinoma and reference samples.
Nacu S; Yuan W; Kan Z; Bhatt D; Rivers CS; Stinson J; Peters BA; Modrusan Z; Jung K; Seshagiri S; Wu TD
BMC Med Genomics; 2011 Jan; 4():11. PubMed ID: 21261984
[TBL] [Abstract][Full Text] [Related]
28. Retention of Interstitial Genes between
Murphy SJ; Kosari F; Karnes RJ; Nasir A; Johnson SH; Gaitatzes AG; Smadbeck JB; Rangel LJ; Vasmatzis G; Cheville JC
Cancer Res; 2017 Nov; 77(22):6157-6167. PubMed ID: 29127096
[No Abstract] [Full Text] [Related]
29. Identification of chimeric TSNAX-DISC1 resulting from intergenic splicing in endometrial carcinoma through high-throughput RNA sequencing.
Li N; Zheng J; Li H; Deng J; Hu M; Wu H; Li W; Li F; Lan X; Lu J; Zhou Y
Carcinogenesis; 2014 Dec; 35(12):2687-97. PubMed ID: 25239642
[TBL] [Abstract][Full Text] [Related]
30. Novel 5' fusion partners of ETV1 and ETV4 in prostate cancer.
Barros-Silva JD; Paulo P; Bakken AC; Cerveira N; Løvf M; Henrique R; Jerónimo C; Lothe RA; Skotheim RI; Teixeira MR
Neoplasia; 2013 Jul; 15(7):720-6. PubMed ID: 23814484
[TBL] [Abstract][Full Text] [Related]
31. Intergenically Spliced Chimeric RNAs in Cancer.
Jia Y; Xie Z; Li H
Trends Cancer; 2016 Sep; 2(9):475-484. PubMed ID: 28210711
[TBL] [Abstract][Full Text] [Related]
32. TMPRSS2:ERG fusion by translocation or interstitial deletion is highly relevant in androgen-dependent prostate cancer, but is bypassed in late-stage androgen receptor-negative prostate cancer.
Hermans KG; van Marion R; van Dekken H; Jenster G; van Weerden WM; Trapman J
Cancer Res; 2006 Nov; 66(22):10658-63. PubMed ID: 17108102
[TBL] [Abstract][Full Text] [Related]
33. Characterization of TMPRSS2:ETV5 and SLC45A3:ETV5 gene fusions in prostate cancer.
Helgeson BE; Tomlins SA; Shah N; Laxman B; Cao Q; Prensner JR; Cao X; Singla N; Montie JE; Varambally S; Mehra R; Chinnaiyan AM
Cancer Res; 2008 Jan; 68(1):73-80. PubMed ID: 18172298
[TBL] [Abstract][Full Text] [Related]
34. N-myc downstream regulated gene 1 (NDRG1) is fused to ERG in prostate cancer.
Pflueger D; Rickman DS; Sboner A; Perner S; LaFargue CJ; Svensson MA; Moss BJ; Kitabayashi N; Pan Y; de la Taille A; Kuefer R; Tewari AK; Demichelis F; Chee MS; Gerstein MB; Rubin MA
Neoplasia; 2009 Aug; 11(8):804-11. PubMed ID: 19649210
[TBL] [Abstract][Full Text] [Related]
35. RNA Splicing of the BHC80 Gene Contributes to Neuroendocrine Prostate Cancer Progression.
Li Y; Xie N; Chen R; Lee AR; Lovnicki J; Morrison EA; Fazli L; Zhang Q; Musselman CA; Wang Y; Huang J; Gleave ME; Collins C; Dong X
Eur Urol; 2019 Aug; 76(2):157-166. PubMed ID: 30910347
[TBL] [Abstract][Full Text] [Related]
36. An intronic splicing silencer causes skipping of the IIIb exon of fibroblast growth factor receptor 2 through involvement of polypyrimidine tract binding protein.
Carstens RP; Wagner EJ; Garcia-Blanco MA
Mol Cell Biol; 2000 Oct; 20(19):7388-400. PubMed ID: 10982855
[TBL] [Abstract][Full Text] [Related]
37. MicroRNA-3188 targets ETS-domain protein 4 and participates in RhoA/ROCK pathway to regulate the development of atherosclerosis.
Li N; Chen J; Zhao J; Wang T
Pharmazie; 2017 Nov; 72(11):687-693. PubMed ID: 29442044
[TBL] [Abstract][Full Text] [Related]
38. Fusion transcript loci share many genomic features with non-fusion loci.
Lai J; An J; Seim I; Walpole C; Hoffman A; Moya L; Srinivasan S; Perry-Keene JL; ; Wang C; Lehman ML; Nelson CC; Clements JA; Batra J
BMC Genomics; 2015 Dec; 16():1021. PubMed ID: 26626734
[TBL] [Abstract][Full Text] [Related]
39. Novel Nine-Exon AR Transcripts (Exon 1/Exon 1b/Exons 2-8) in Normal and Cancerous Breast and Prostate Cells.
Hu DG; McKinnon RA; Hulin JA; Mackenzie PI; Meech R
Int J Mol Sci; 2016 Dec; 18(1):. PubMed ID: 28035996
[TBL] [Abstract][Full Text] [Related]
40. miR-32 and its target SLC45A3 regulate the lipid metabolism of oligodendrocytes and myelin.
Shin D; Howng SY; Ptáček LJ; Fu YH
Neuroscience; 2012 Jun; 213():29-37. PubMed ID: 22521588
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
